[Management of the cardiovascular complications of treatment in thoracic oncology]

Abstract

The management of patients suffering from bronchial and lung tumors depends on conventional chemotherapy and/or targeted molecular therapies. The prescription of these chemotherapies may be accompanied by cardiovascular complications, principally congestive heart failure, arterial hypertension and arterial or venous thrombo-embolism, the frequency of which varies with the molecule administered. The management of these complications is currently poorly standardized and should take account of the patient's oncological prognosis.

Keywords: Anti-angiogenic; Anti-angiogénique; Arterial hypertension; Chemotherapy; Chimiothérapie; Congestive heart failure; Hypertension artérielle; Insuffisance cardiaque.